Method for fully automated synthesis of 16β-18F-fluoro-5α-dihydrotestosterone (18F-FDHT)

Patent metadata

Field	Value
Publication number	US-10065985-B2
Application number	US-201615545924-A
Country	US
Kind code	B2
Filing date	Feb 3, 2016
Priority date	Feb 3, 2015
Publication date	Sep 4, 2018
Grant date	Sep 4, 2018

Abstract

The automated synthesis of clinically relevant amounts of 16β-18F-fluoro-5α-dihydrotestosterone (18F-FDHT) using a commercially available radiosynthesizer. Synthesis was performed in 90 minutes with a decay-corrected radiochemical yield of 29±5%. The specific activity was 4.6 Ci/μmol (170 GBq/μmol) at end of formulation with a starting activity of 1.0 Ci (37 GBq). The formulated 18F-FDHT yielded sufficient activity for multiple patient doses and passed all quality control tests required for routine clinical use.

First claim

What is claimed is:

1. A method for the automated synthesis of 16β- 18 F-fluoro-5α-dihydrotestosterone ( 18 F-FDHT) comprising:
loading a plurality of reagents in an automated radiosynthesizer, the automated radiosynthesizer comprising a cassette and a reactor disposed beneath the cassette, wherein at least some of the reagents are stored on the cassette;
executing a synthesis program on the automated radiosynthesizer, the synthesis program comprising:
eluting 18 F-fluoride into a reactor vial contained in the reactor via the cassette;
adding acetonitrile reagent via the cassette into the reactor vial and evaporating the contents thereof with the reactor;
cooling the reactor vial and adding a precursor solution comprising 16α-[[(trifluoromethyl)sulfonyl]oxy]-3,3-(ethylenedioxy)androstan-17-one via the cassette;
reacting the precursor solution within the reactor vial at elevated temperature under stirring conditions;
cooling the reactor vial to approximately room temperature and adding a solution of LiAlH 4 via the cassette followed by stirring;
adding acetone-THF solution into the reactor vial via the cassette followed by stirring;
adding HCl solution into the reactor vial via the cassette and reacting the same at elevated temperature under stirring conditions;
cooling the reactor vial and transferring the contents through a hydrophilic-lipophilic balanced (HLB) cartridge so as to trap product therein;
rinsing the reaction container and the HLB cartridge with water;
drying the HLB cartridge under an inert gas; and
passing dichloromethane (DCM) reagent into the HLB cartridge so as to elute 18 F-FDHT from the HLB cartridge.

2. The method of claim 1 , further comprising transferring the 18 F-FDHT into a HPLC loop associated with the automated radiosynthesizer to purify the 18 F-FDHT.

3. The method of claim 2 , further comprising reformulating the purified 18 F-FDHT with ethanol and sterile saline.

4. A method for the automated synthesis of 16β- 18 F-fluoro-5α-dihydrotestosterone ( 18 F-FDHT) comprising:
loading a plurality of reagents in an automated radiosynthesizer, the radiosynthesizer comprising a first reactor, a second reactor, a first cassette disposed above the first reactor, and a second cassette disposed above the second reactor, wherein each of the first and second cassettes define fluid passageways for reagents and reaction products and provide respective contact surfaces for vials respectively contained in the first and second reactors;
executing a synthesis program on the automated radiosynthesizer, the synthesis program comprising:
eluting 18 F-fluoride into the vial of the first reactor through the first cassette;
adding acetonitrile into the vial of the first reactor through the first cassette;
contacting the vial of the first reactor against the first cassette and evaporating the contents;
cooling the vial of the first reactor and adding a precursor solution comprising 16α-[[(trifluoromethyl)sulfonyl]oxy]-3,3-(ethylenedioxy)androstan-17-one through the first cassette;
heating the precursor solution within the vial of the first reactor at elevated temperature under stirring conditions;
cooling the vial of the first reactor to approximately room temperature and adding a solution of LiAlH 4 via the first cassette followed by stirring;
adding acetone-THF solution via the first cassette into the vial of the first reactor followed by stirring;
adding HCl solution via the first cassette and heating to elevated temperature under stirring conditions;
cooling the vial of the first reactor and transferring the contents through a hydrophilic-lipophilic balanced (HLB) cartridge coupled to the first cassette so as to trap product therein and transferring waste 18 F-fluoride to a waste vial coupled to the first cassette;
rinsing the vial of the first reactor and the HLB cartridge with water via the first cassette;
drying the HLB cartridge under an inert gas;
passing dichloromethane (DCM) through the first cassette and into the HLB cartridge so as to elute 18 F-FDHT from the HLB cartridge and transferring the same to the vial of the second reactor via the second cassette; and

transferring the contents of the vial of the second reactor via the second cassette into an HPLC loop associated with the automated radiosynthesizer to purify the 18 F-FDHT.

5. The method of claim 4 , further comprising reformulating the purified 18 F-FDHT with ethanol and sterile saline.

6. The method of claim 4 , wherein the acetonitrile, precursor solution, LiAlH 4 solution, HCl solution, rinse water solution are stored in vials disposed on the first cassette.

7. The method of claim 4 , wherein the synthesis program comprises a sequence of synthesis operations stored as instructions within computer software associated with the automated radiosynthesizer and the automated radiosynthesizer executes the synthesis operations automatically without operator involvement in accordance with the stored instructions.

8. The method of claim 4 , wherein the addition of LiAlH 4 solution and acetone-THF solution are added at a rate lower than the rate of addition of other reagents.

9. The method of claim 4 , wherein the acetone-THF solution comprises about 0.10 mL of acetone diluted with 0.25 mL of THF or an equivalent volumetric fraction.

10. The method of claim 4 , wherein the acetone-THF solution is added after about 20 seconds after the addition of the LiAlH 4 solution.

11. The method of claim 4 , wherein the output of the HLB cartridge is coupled to at least one downstream desiccant cartridge comprising a Na 2 SO 4 cartridge.

12. The method of claim 11 , wherein the at least one downstream desiccant cartridge further comprises a MgSO 4 cartridge.

13. The method of claim 4 , wherein the 18 F-FDHT has specific activity greater than 1 Ci/μmol.

14. The method of claim 4 , wherein the vial of the first reactor that contains the added HCL solution is contacted with a contact surface of the first cartridge.

Assignees

• Univ California

Inventors

• Murphy Jennifer Marie
• Lazari Mark Saul

Classifications

• B01J2219/00927

  Particle radiation or gamma-radiation · CPC title

• B01J2219/00889

  Mixing · CPC title

• B01J2219/00799

  Cup-shaped · CPC title

• B01J2219/00813

  Fluidic connections · CPC title

• C07J1/0022

  the substituent being an OH group free esterified or etherified · CPC title